Stephan Grupp, MD, PhD | Authors

Articles

CAR T Cell Data for Pediatric and Young Adult Patients With Relapsed/Refractory ALL

January 09, 2019

Stephan Grupp, MD, PhD, discusses updated findings from the phase II ELIANA trial of tisagenlecleucel (Kymriah), a chimeric antigen receptor T-cell therapy, in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia with high disease burden.